相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Global health concerns stirred by emerging viral infections
Guangxiang (George) Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
COVID-19: combining antiviral and anti-inflammatory treatments
Justin Stebbing et al.
LANCET INFECTIOUS DISEASES (2020)
Medicinal chemistry strategies toward host targeting antiviral agents
Xingyue Ji et al.
MEDICINAL RESEARCH REVIEWS (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics
Arun K. Ghosh et al.
CHEMMEDCHEM (2020)
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Mechanism of baricitinib supports artificial intelligence-predicted testing inCOVID-19 patients
Justin Stebbing et al.
EMBO MOLECULAR MEDICINE (2020)
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing
Oleg O. Glebov
FEBS JOURNAL (2020)
Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus
Sandrine Vendeville et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
COVID-19: Drug Targets and Potential Treatments
Carmen Gil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Repurposing of Kinase Inhibitors for Treatment of COVID-19
Ellen Weisberg et al.
PHARMACEUTICAL RESEARCH (2020)
Structural basis of RNA cap modification by SARS-CoV-2
Thiruselvam Viswanathan et al.
NATURE COMMUNICATIONS (2020)
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin
Petra Krafcikova et al.
NATURE COMMUNICATIONS (2020)
Discovery of Potent and Selective PI3Kγ Inhibitors
Samuel L. Drew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors
Dillon H. Miles et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
The immunology of COVID-19: is immune modulation an option for treatment?
Jixin Zhong et al.
LANCET RHEUMATOLOGY (2020)
A class of highly selective inhibitors bind to an active state of PI3Kγ
Gangadhara Gangadhara et al.
NATURE CHEMICAL BIOLOGY (2019)
Respiratory syncytial virus entry and how to block it
Michael B. Battles et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3-b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity
Sven Verdonck et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Update on HIV integrase inhibitors for the treatment of HIV-1 infection
Blake Max
FUTURE VIROLOGY (2019)
Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region
David C. McGowan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Heterocycles in Medicinal Chemistry
Josef Jampilek
MOLECULES (2019)
A review of Dengvaxia?: development to deployment
Stephen J. Thomas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
State of the Art in Respiratory Syncytial Virus Drug Discovery and Development
G. Stuart Cockerill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
Yen-Ting Lai et al.
NATURE COMMUNICATIONS (2019)
Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
Nicholas A. Meanwell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors
Takayuki Irie et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2018)
Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Stanford Schor et al.
DNA AND CELL BIOLOGY (2018)
Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir
Tao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Influenza
Florian Krammer et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
Kuldeep Dhama et al.
FRONTIERS IN IMMUNOLOGY (2018)
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Cameron Griffiths et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Neurotropic alphaviruses can propagate without capsid
Marta Ruiz-Guillen et al.
ONCOTARGET (2017)
Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors
Song Feng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization
Lewis D. Pennington et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529
Marie Pancera et al.
NATURE CHEMICAL BIOLOGY (2017)
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2
Luc J. Farmer et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza
Upul K. Bandarage et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
Dirk Roymans et al.
NATURE COMMUNICATIONS (2017)
Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41
Lu Lu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates
Rolando Cannalire et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors
Benedicte Dayde-Cazals et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
HIV Genome-Wide Protein Associations: a Review of 30 Years of Research
Guangdi Li et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Modern advances in heterocyclic chemistry in drug discovery
Alexandria P. Taylor et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Family-wide Structural Analysis of Human Numb-Associated Protein Kinases
Fiona J. Sorrell et al.
STRUCTURE (2016)
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
April M. Killikelly et al.
SCIENTIFIC REPORTS (2016)
HIV pharmacotherapy: A review of integrase inhibitors
Elaine Wong et al.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS (2016)
Novel Dioxolan Derivatives of Indole as HIV-1 Integrase Strand Transfer Inhibitors Active Against RAL Resistant Mutant Virus
Raja Singh et al.
CHEMISTRYSELECT (2016)
Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication
Olivia Perwitasari et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)
Kinase hinge binding scaffolds and their hydrogen bond patterns
Li Xing et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors
Michael J. Boyd et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B
Guangming Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study
Richard L. Mackman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Applications of Fluorine in Medicinal Chemistry
Eric P. Gillis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
HIV-1 assembly, release and maturation
Eric O. Freed
NATURE REVIEWS MICROBIOLOGY (2015)
Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry
Sayantan Bose et al.
VIROLOGY (2015)
Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors
Vibha Tandon et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit
Randal A. Byrn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase
Ying Sun et al.
ANTIVIRAL RESEARCH (2014)
Discovery and optimization of novel small-molecule HIV-1 entry inhibitors using field-based virtual screening and bioisosteric replacement
Marina Tuyishime et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Structure-Activity Relationship (SAR) Optimization of 6-(Indol-2-yl)pyridine-3-sulfonamides: Identification of Potent, Selective, and Orally Bioavailable Small Molecules Targeting Hepatitis C (HCV) NS4B
Nanjing Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among US FDA Approved Pharmaceuticals
Edon Vitaku et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
Michael P. Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Proton transfer reactions and hydrogen-bond networks in protein environments
Hiroshi Ishikita et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
Novel Indole-2-Carboxamide Compounds Are Potent Broad-Spectrum Antivirals Active against Western Equine Encephalitis Virus In Vivo
Phillip C. Delekta et al.
JOURNAL OF VIROLOGY (2014)
The Azaindole Framework in the Design of Kinase Inhibitors
Jean-Yves Merour et al.
MOLECULES (2014)
New dolutegravir resistance pattern identified in a patient failing antiretroviral therapy
Andreas Carganico et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)
Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness
Michael E. Abram et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Entry inhibitors and their use in the treatment of HIV-1 infection
Aiman A. Haqqani et al.
ANTIVIRAL RESEARCH (2013)
Inhibitors of HIV-1 attachment. Part 8: The effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors
Kap-Sun Yeung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents
Kap-Sun Yeung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inhibitors of HIV-1 attachment. Part 10. The discovery and structure-activity relationships of 4-azaindole cores
Tao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Respiratory Syncytial Virus-A Comprehensive Review
Andrea T. Borchers et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
Rainer Wilcken et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 12. Structure-Activity Relationships Associated with 4-Fluoro-6-azaindole Derivatives Leading to the Identification of 1-(4-Benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-585248)
Alicia Regueiro-Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Optimization of Novel Indole-2-carboxamide Inhibitors of Neurotropic Alphavirus Replication
Janice A. Sindac et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Neurotropic Arboviruses Induce Interferon Regulatory Factor 3-Mediated Neuronal Responses That Are Cytoprotective, Interferon Independent, and Inhibited by Western Equine Encephalitis Virus Capsid
Daniel C. Peltier et al.
JOURNAL OF VIROLOGY (2013)
Past, present and future: 30 years of HIV research
Francoise Barre-Sinoussi et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis
Peter Messiaen et al.
PLOS ONE (2013)
Recent advances in the synthesis and properties of 4-, 5-, 6-or 7-azaindoles
Jean-Yves Merour et al.
TETRAHEDRON (2013)
Discovery of an HIV integrase inhibitor with an excellent resistance profile
David C. Pryde et al.
MEDCHEMCOMM (2013)
Chemically Programmed Antibodies As HIV-1 Attachment Inhibitors
Shinichi Sato et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Probing water micro-solvation in proteins by water catalysed proton-transfer tautomerism
Jiun-Yi Shen et al.
NATURE COMMUNICATIONS (2013)
Host Cell Entry of Respiratory Syncytial Virus Involves Macropinocytosis Followed by Proteolytic Activation of the F Protein
Magdalena Anna Krzyzaniak et al.
PLOS PATHOGENS (2013)
Prophylaxis and Treatment of Respiratory Syncytial Virus in Adult Immunocompromised Patients
Lauren M. Hynicka et al.
ANNALS OF PHARMACOTHERAPY (2012)
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)
John F. Kadow et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Novel Inhibitors of Neurotropic Alphavirus Replication That Improve Host Survival in a Mouse Model of Acute Viral Encephalitis
Janice A. Sindac et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Cholesterol-Rich Microdomains as Docking Platforms for Respiratory Syncytial Virus in Normal Human Bronchial Epithelial Cells
Homero San-Juan-Vergara et al.
JOURNAL OF VIROLOGY (2012)
The structural biology of HIV-1: mechanistic and therapeutic insights
Alan Engelman et al.
NATURE REVIEWS MICROBIOLOGY (2012)
CURRENT CONCEPTS Dengue
Cameron P. Simmons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Probing chelation motifs in HIV integrase inhibitors
Arpita Agrawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure-activity relationships, physicochemical properties and biological activity
Antoni R. Blaazer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors
Ted W. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
New Merck and Vertex drugs raise standard of care in hepatitis C
Cormac Sheridan
NATURE BIOTECHNOLOGY (2011)
Recent Experimental Advances on Excited-State Intramolecular Proton Coupled Electron Transfer Reaction
Cheng-Chih Hsieh et al.
ACCOUNTS OF CHEMICAL RESEARCH (2010)
Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers
Sherene Min et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Entry inhibitors in the treatment of HIV-1 infection
John C. Tilton et al.
ANTIVIRAL RESEARCH (2010)
Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK
Steven P. Tanis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Privileged scaffolds for library design and drug discovery
Matthew E. Welsch et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Biological Importance of the Indole Nucleus in Recent Years: A Comprehensive Review
Vikas Sharma et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2010)
Excited state double proton transfer of a 1:1 7-azaindole:H2O complex and the breakdown of the rule of the geometric mean: Variational transition state theory studies including multidimensional tunneling
My Phu Thi Duong et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2010)
A cooperative and specific DNA-binding mode of HIV-1 integrase depends on the nature of the metallic cofactor and involves the zinc-containing N-terminal domain
Kevin Carayon et al.
NUCLEIC ACIDS RESEARCH (2010)
Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation
Abdul S. Yunus et al.
VIROLOGY (2010)
Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns
Nicholas A. Meanwell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Variolins and Related Alkaloids
Scoff R. Walker et al.
CHEMICAL REVIEWS (2009)
Identification of Thieno[3,2-b]Pyrrole Derivatives as Novel Small Molecule Inhibitors of Neurotropic Alphaviruses
Weiping Peng et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors
Michael B. Plewe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
From Nature to Drug Discovery: The Indole Scaffold as a 'Privileged Structure'
Fernando Rodrigues de Sa Alves et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Architecture and secondary structure of an entire HIV-1 RNA genome
Joseph M. Watts et al.
NATURE (2009)
HIV Entry Inhibitors and Their Potential in HIV Therapy
Keduo Qian et al.
MEDICINAL RESEARCH REVIEWS (2009)
HIV-1 entry inhibitors: an overview
Daniel R. Kuritzkes
CURRENT OPINION IN HIV AND AIDS (2009)
Clinical progress of HIV-1 integrase inhibitors
Laith Q. Al-Mawsawi et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Discovery of Raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection
Vincenzo Summa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Raltegravir with optimized background therapy for resistant HIV-1 infection
Roy T. Steigbigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Influenza vaccine: The challenge of antigenic drift
F. Carrat et al.
VACCINE (2007)
A platform for designing HIV integrase inhibitors. Part 2: A two-metal binding model as a potential mechanism of HIV integrase inhibitors
Takashi Kawasuji et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics
M Sato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose
P Yuan et al.
STRUCTURE (2005)
Vpr and vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo
E Rücker et al.
JOURNAL OF VIROLOGY (2004)
Incorporation of the fluorescent amino acid 7-azatryptophan into the core domain 1-47 of hirudin as a probe of hirudin folding and thrombin recognition
V De Filippis et al.
PROTEIN SCIENCE (2004)
Discovery of 4-benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]lpyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine (BMS-378806):: A novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions
T Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Excited-state intramolecular proton transfer in five-membered hydrogen-bonding systems: 2-pyridyl pyrazoles
WS Yu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
The combinatorial synthesis of bicyclic privileged structures or privileged substructures
DA Horton et al.
CHEMICAL REVIEWS (2003)
The photophysical properties of 6-azaindole
SM Twine et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2003)
A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition
GE Blouse et al.
BIOCHEMISTRY (2002)
Development of a novel influenza A antiviral assay
PC Wagaman et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: A physiologically based pharmacokinetic model
K Yokogawa et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2002)
分享论文
